{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:22:28Z","timestamp":1788492148358,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Usher syndrome is an inherited and irreversible disease that manifests as retinitis pigmentosa (RP) and bilateral neurosensory hearing loss. Mutations in <jats:italic>Usherin 2A (USH2A)<\/jats:italic> are not only a frequent cause of Usher syndrome, but also nonsyndromic RP. Although gene- and cell-based therapies are on the horizon for RP and Usher syndrome, studies characterizing natural disease are lacking. In this retrospective analysis, retinal function of <jats:italic>USH2A<\/jats:italic> patients was quantified with electroretinography. Both groups had markedly reduced rod and cone responses, but nonsyndromic <jats:italic>USH2A<\/jats:italic> patients had 30\u2009Hz-flicker electroretinogram amplitudes that were significantly higher than syndromic patients, suggesting superior residual cone function. There was a tendency for Usher syndrome patients to have a higher distribution of severe mutations, and alleles in this group had a higher odds of containing nonsense or frame-shift mutations. These data suggest that the previously reported severe visual phenotype seen in syndromic <jats:italic>USH2A<\/jats:italic> patients could relate to a greater extent of cone dysfunction. Additionally, a genetic threshold may exist where mutation burden relates to visual phenotype and the presence of hearing deficits. The auditory phenotype and allelic hierarchy observed among patients should be considered in prospective studies of disease progression and during enrollment for future clinical trials.<\/jats:p>","DOI":"10.1038\/s41598-017-11679-y","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T14:24:28Z","timestamp":1504621468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Electroretinography Reveals Difference in Cone Function between Syndromic and Nonsyndromic USH2A Patients"],"prefix":"10.1038","volume":"7","author":[{"given":"Jesse D.","family":"Sengillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Schuerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Boudreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-1460","authenticated-orcid":false,"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Justus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet R.","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"11679_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0021-9681(83)90147-9","volume":"36","author":"JA Boughman","year":"1983","unstructured":"Boughman, J. A., Vernon, M. & Shaver, K. A. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis \n                           36, 595\u2013603 (1983).","journal-title":"J Chronic Dis"},{"key":"11679_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.0.CO;2-#","volume":"89","author":"BJ Keats","year":"1999","unstructured":"Keats, B. J. & Corey, D. P. The usher syndromes. Am J Med Genet \n                           89, 158\u2013166 (1999).","journal-title":"Am J Med Genet"},{"key":"11679_CR3","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/ajmg.a.37855","volume":"170","author":"D Mehta","year":"2016","unstructured":"Mehta, D. et al. Outcomes of evaluation and testing of 660 individuals with hearing loss in a pediatric genetics of hearing loss clinic. Am J Med Genet A \n                           170, 2523\u20132530, doi:https:\/\/doi.org\/10.1002\/ajmg.a.37855 (2016).","journal-title":"Am J Med Genet A"},{"key":"11679_CR4","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2741\/3979","volume":"17","author":"J Yang","year":"2012","unstructured":"Yang, J., Wang, L., Song, H. & Sokolov, M. Current understanding of usher syndrome type II. Front Biosci (Landmark Ed) \n                           17, 1165\u20131183 (2012).","journal-title":"Front Biosci (Landmark Ed)"},{"key":"11679_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbadis.2014.11.020","volume":"1852","author":"P Mathur","year":"2015","unstructured":"Mathur, P. & Yang, J. Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities. Biochim Biophys Acta \n                           1852, 406\u2013420, doi:https:\/\/doi.org\/10.1016\/j.bbadis.2014.11.020 (2015).","journal-title":"Biochim Biophys Acta"},{"key":"11679_CR6","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1167\/iovs.08-2009","volume":"49","author":"MA Sandberg","year":"2008","unstructured":"Sandberg, M. A. et al. Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene. Invest Ophthalmol Vis Sci \n                           49, 5532\u20135539, doi:https:\/\/doi.org\/10.1167\/iovs.08-2009 (2008).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11679_CR7","doi-asserted-by":"publisher","unstructured":"Sengillo, J. D., Justus, S., Cabral, T. & Tsang, S. H. Correction of Monogenic and Common Retinal Disorders with Gene Therapy. Genes (Basel) \n                           8, doi:https:\/\/doi.org\/10.3390\/genes8020053 (2017).","DOI":"10.3390\/genes8020053"},{"key":"11679_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajmg.c.31534","volume":"172","author":"JD Sengillo","year":"2016","unstructured":"Sengillo, J. D., Justus, S., Tsai, Y. T., Cabral, T. & Tsang, S. H. Gene and cell-based therapies for inherited retinal disorders: An update. Am J Med Genet C Semin Med Genet \n                           172, 349\u2013366, doi:https:\/\/doi.org\/10.1002\/ajmg.c.31534 (2016).","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"11679_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.otc.2015.07.007","volume":"48","author":"T Koffler","year":"2015","unstructured":"Koffler, T., Ushakov, K. & Avraham, K. B. Genetics of Hearing Loss: Syndromic. Otolaryngol Clin North Am \n                           48, 1041\u20131061, doi:https:\/\/doi.org\/10.1016\/j.otc.2015.07.007 (2015).","journal-title":"Otolaryngol Clin North Am"},{"key":"11679_CR10","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1093\/hmg\/ddi416","volume":"14","author":"A Adato","year":"2005","unstructured":"Adato, A. et al. Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. Hum Mol Genet \n                           14, 3921\u20133932, doi:https:\/\/doi.org\/10.1093\/hmg\/ddi416 (2005).","journal-title":"Hum Mol Genet"},{"key":"11679_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00018-011-0749-8","volume":"69","author":"SM Heissler","year":"2012","unstructured":"Heissler, S. M. & Manstein, D. J. Functional characterization of the human myosin-7a motor domain. Cell Mol Life Sci \n                           69, 299\u2013311, doi:https:\/\/doi.org\/10.1007\/s00018-011-0749-8 (2012).","journal-title":"Cell Mol Life Sci"},{"key":"11679_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.exer.2005.11.010","volume":"83","author":"J Reiners","year":"2006","unstructured":"Reiners, J., Nagel-Wolfrum, K., Jurgens, K., Marker, T. & Wolfrum, U. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res \n                           83, 97\u2013119, doi:https:\/\/doi.org\/10.1016\/j.exer.2005.11.010 (2006).","journal-title":"Exp Eye Res"},{"key":"11679_CR13","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1093\/hmg\/ddi417","volume":"14","author":"J Reiners","year":"2005","unstructured":"Reiners, J. et al. Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. Hum Mol Genet \n                           14, 3933\u20133943, doi:https:\/\/doi.org\/10.1093\/hmg\/ddi417 (2005).","journal-title":"Hum Mol Genet"},{"key":"11679_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000955","volume":"6","author":"J Yang","year":"2010","unstructured":"Yang, J. et al. Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss. PLoS Genet \n                           6, e1000955, doi:https:\/\/doi.org\/10.1371\/journal.pgen.1000955 (2010).","journal-title":"PLoS Genet"},{"key":"11679_CR15","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/hmg\/ddt629","volume":"23","author":"J Zou","year":"2014","unstructured":"Zou, J. et al. Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice. Hum Mol Genet \n                           23, 2374\u20132390, doi:https:\/\/doi.org\/10.1093\/hmg\/ddt629 (2014).","journal-title":"Hum Mol Genet"},{"key":"11679_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/GIM.0b013e3181e5afb8","volume":"12","author":"WJ Kimberling","year":"2010","unstructured":"Kimberling, W. J. et al. Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children. Genet Med \n                           12, 512\u2013516, doi:https:\/\/doi.org\/10.1097\/GIM.0b013e3181e5afb8 (2010).","journal-title":"Genet Med"},{"key":"11679_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.1.e8","volume":"40","author":"S Bernal","year":"2003","unstructured":"Bernal, S. et al. Mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa: high prevalence and phenotypic variation. J Med Genet \n                           40, e8 (2003).","journal-title":"J Med Genet"},{"key":"11679_CR18","first-page":"1398","volume":"20","author":"G Garcia-Garcia","year":"2014","unstructured":"Garcia-Garcia, G. et al. Novel deletions involving the USH2A gene in patients with Usher syndrome and retinitis pigmentosa. Mol Vis \n                           20, 1398\u20131410 (2014).","journal-title":"Mol Vis"},{"key":"11679_CR19","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/ejhg.2014.283","volume":"23","author":"E Lenassi","year":"2015","unstructured":"Lenassi, E. et al. A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants. Eur J Hum Genet \n                           23, 1318\u20131327, doi:https:\/\/doi.org\/10.1038\/ejhg.2014.283 (2015).","journal-title":"Eur J Hum Genet"},{"key":"11679_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jmg.2009.075143","volume":"47","author":"TL McGee","year":"2010","unstructured":"McGee, T. L., Seyedahmadi, B. J., Sweeney, M. O., Dryja, T. P. & Berson, E. L. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. J Med Genet \n                           47, 499\u2013506, doi:https:\/\/doi.org\/10.1136\/jmg.2009.075143 (2010).","journal-title":"J Med Genet"},{"key":"11679_CR21","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1086\/302926","volume":"66","author":"C Rivolta","year":"2000","unstructured":"Rivolta, C., Sweklo, E. A., Berson, E. L. & Dryja, T. P. Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. Am J Hum Genet \n                           66, 1975\u20131978, doi:https:\/\/doi.org\/10.1086\/302926 (2000).","journal-title":"Am J Hum Genet"},{"key":"11679_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.exer.2004.03.005","volume":"79","author":"BJ Seyedahmadi","year":"2004","unstructured":"Seyedahmadi, B. J., Rivolta, C., Keene, J. A., Berson, E. L. & Dryja, T. P. Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. Exp Eye Res \n                           79, 167\u2013173, doi:https:\/\/doi.org\/10.1016\/j.exer.2004.03.005 (2004).","journal-title":"Exp Eye Res"},{"key":"11679_CR23","first-page":"1537","volume":"17","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Seven novel mutations in the long isoform of the USH2A gene in Chinese families with nonsyndromic retinitis pigmentosa and Usher syndrome Type II. Mol Vis \n                           17, 1537\u20131552 (2011).","journal-title":"Mol Vis"},{"key":"11679_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ophtha.2016.01.021","volume":"123","author":"LH Pierrache","year":"2016","unstructured":"Pierrache, L. H. et al. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa. Ophthalmology \n                           123, 1151\u20131160, doi:https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.021 (2016).","journal-title":"Ophthalmology"},{"key":"11679_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ajo.2015.06.032","volume":"160","author":"T Sujirakul","year":"2015","unstructured":"Sujirakul, T. et al. Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa. Am J Ophthalmol \n                           160, 786\u2013798 e784, doi:https:\/\/doi.org\/10.1016\/j.ajo.2015.06.032 (2015).","journal-title":"Am J Ophthalmol"},{"key":"11679_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.exer.2007.03.001","volume":"85","author":"EL Berson","year":"2007","unstructured":"Berson, E. L. Long-term visual prognoses in patients with retinitis pigmentosa: the Ludwig von Sallmann lecture. Exp Eye Res \n                           85, 7\u201314, doi:https:\/\/doi.org\/10.1016\/j.exer.2007.03.001 (2007).","journal-title":"Exp Eye Res"},{"key":"11679_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archopht.1993.01090060049022","volume":"111","author":"EL Berson","year":"1993","unstructured":"Berson, E. L. et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol \n                           111, 761\u2013772 (1993).","journal-title":"Arch Ophthalmol"},{"key":"11679_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1001\/archophthalmol.2010.32","volume":"128","author":"EL Berson","year":"2010","unstructured":"Berson, E. L. et al. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol \n                           128, 403\u2013411, doi:https:\/\/doi.org\/10.1001\/archophthalmol.2010.32 (2010).","journal-title":"Arch Ophthalmol"},{"key":"11679_CR29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/archopht.122.9.1297","volume":"122","author":"EL Berson","year":"2004","unstructured":"Berson, E. L. et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol \n                           122, 1297\u20131305, doi:https:\/\/doi.org\/10.1001\/archopht.122.9.1297 (2004).","journal-title":"Arch Ophthalmol"},{"key":"11679_CR30","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1167\/iovs.10-6932","volume":"52","author":"A Schatz","year":"2011","unstructured":"Schatz, A. et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Invest Ophthalmol Vis Sci \n                           52, 4485\u20134496, doi:https:\/\/doi.org\/10.1167\/iovs.10-6932 (2011).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11679_CR31","first-page":"122","volume":"8","author":"DZ Wu","year":"1992","unstructured":"Wu, D. Z., Liang, J., Wu, L., Luo, T. & Yu, M. Quantitative evaluation of flicker ERG waveforms in low vision patients. Yan Ke Xue Bao \n                           8, 122\u2013125 (1992).","journal-title":"Yan Ke Xue Bao"},{"key":"11679_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/138920211795860116","volume":"12","author":"S Chang","year":"2011","unstructured":"Chang, S., Vaccarella, L., Olatunji, S., Cebulla, C. & Christoforidis, J. Diagnostic challenges in retinitis pigmentosa: genotypic multiplicity and phenotypic variability. Curr Genomics \n                           12, 267\u2013275, doi:https:\/\/doi.org\/10.2174\/138920211795860116 (2011).","journal-title":"Curr Genomics"},{"key":"11679_CR33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.ophtha.2010.06.041","volume":"118","author":"MI Khan","year":"2011","unstructured":"Khan, M. I. et al. CLRN1 mutations cause nonsyndromic retinitis pigmentosa. Ophthalmology \n                           118, 1444\u20131448, doi:https:\/\/doi.org\/10.1016\/j.ophtha.2010.10.047 (2011).","journal-title":"Ophthalmology"},{"key":"11679_CR34","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/humu.20677","volume":"29","author":"S Riazuddin","year":"2008","unstructured":"Riazuddin, S. et al. Mutation spectrum of MYO7A and evaluation of a novel nonsyndromic deafness DFNB2 allele with residual function. Hum Mutat \n                           29, 502\u2013511, doi:https:\/\/doi.org\/10.1002\/humu.20677 (2008).","journal-title":"Hum Mutat"},{"key":"11679_CR35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jmedgenet-2011-100262","volume":"48","author":"JM Schultz","year":"2011","unstructured":"Schultz, J. M. et al. Allelic hierarchy of CDH23 mutations causing non-syndromic deafness DFNB12 or Usher syndrome USH1D in compound heterozygotes. J Med Genet \n                           48, 767\u2013775, doi:https:\/\/doi.org\/10.1136\/jmedgenet-2011-100262 (2011).","journal-title":"J Med Genet"},{"key":"11679_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.11.e118","volume":"40","author":"A Iannaccone","year":"2003","unstructured":"Iannaccone, A. et al. Clinical and immunohistochemical evidence for an X linked retinitis pigmentosa syndrome with recurrent infections and hearing loss in association with an RPGR mutation. J Med Genet \n                           40, e118 (2003).","journal-title":"J Med Genet"},{"key":"11679_CR37","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1126\/science.280.5370.1753","volume":"280","author":"JD Eudy","year":"1998","unstructured":"Eudy, J. D. et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science \n                           280, 1753\u20131757 (1998).","journal-title":"Science"},{"key":"11679_CR38","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1086\/302855","volume":"66","author":"MD Weston","year":"2000","unstructured":"Weston, M. D. et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet \n                           66, 1199\u20131210 (2000).","journal-title":"Am J Hum Genet"},{"key":"11679_CR39","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/jhg.2009.107","volume":"54","author":"D Yan","year":"2009","unstructured":"Yan, D. et al. Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II. J Hum Genet \n                           54, 732\u2013738, doi:https:\/\/doi.org\/10.1038\/jhg.2009.107 (2009).","journal-title":"J Hum Genet"},{"key":"11679_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/MAO.0b013e3182877ef2","volume":"34","author":"KR Jatana","year":"2013","unstructured":"Jatana, K. R. et al. Usher syndrome: characteristics and outcomes of pediatric cochlear implant recipients. Otol Neurotol \n                           34, 484\u2013489, doi:https:\/\/doi.org\/10.1097\/MAO.0b013e3182877ef2 (2013).","journal-title":"Otol Neurotol"},{"key":"11679_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094272","volume":"l","author":"M Zallocchi","year":"2014","unstructured":"Zallocchi, M. et al. EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat. PLoS One \n                           l, e94272, doi:https:\/\/doi.org\/10.1371\/journal.pone.0094272 (2014).","journal-title":"PLoS One"},{"key":"11679_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nm.3106","volume":"19","author":"JJ Lentz","year":"2013","unstructured":"Lentz, J. J. et al. Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nat Med \n                           19, 345\u2013350, doi:https:\/\/doi.org\/10.1038\/nm.3106 (2013).","journal-title":"Nat Med"},{"key":"11679_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.89","volume":"5","author":"RW Slijkerman","year":"2016","unstructured":"Slijkerman, R. W. et al. Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation. Mol Ther Nucleic Acids \n                           5, e381, doi:https:\/\/doi.org\/10.1038\/mtna.2016.89 (2016).","journal-title":"Mol Ther Nucleic Acids"},{"key":"11679_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.exer.2013.05.003","volume":"113","author":"JH Acton","year":"2013","unstructured":"Acton, J. H. et al. Evaluation of multimodal imaging in carriers of X-linked retinitis pigmentosa. Exp Eye Res \n                           113, 41\u201348, doi:https:\/\/doi.org\/10.1016\/j.exer.2013.05.003 (2013).","journal-title":"Exp Eye Res"},{"key":"11679_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch, D. L. et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol \n                           130, 1\u201312, doi:https:\/\/doi.org\/10.1007\/s10633-014-9473-7 (2015).","journal-title":"Doc Ophthalmol"},{"key":"11679_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/0002-9394(88)90241-3","volume":"105","author":"SO Andreasson","year":"1988","unstructured":"Andreasson, S. O., Sandberg, M. A. & Berson, E. L. Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa. Am J Ophthalmol \n                           105, 500\u2013503 (1988).","journal-title":"Am J Ophthalmol"},{"key":"11679_CR47","first-page":"1462","volume":"39","author":"PA Sieving","year":"1998","unstructured":"Sieving, P. A., Arnold, E. B., Jamison, J., Liepa, A. & Coats, C. Submicrovolt flicker electroretinogram: cycle-by-cycle recording of multiple harmonics with statistical estimation of measurement uncertainty. Invest Ophthalmol Vis Sci \n                           39, 1462\u20131469 (1998).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11679_CR48","doi-asserted-by":"publisher","first-page":"8006","DOI":"10.1167\/iovs.11-7693","volume":"52","author":"TR Burke","year":"2011","unstructured":"Burke, T. R. et al. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1). Invest Ophthalmol Vis Sci \n                           52, 8006\u20138015, doi:https:\/\/doi.org\/10.1167\/iovs.11-7693 (2011).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"11679_CR49","doi-asserted-by":"publisher","unstructured":"Lee, W. et al. Genotypic spectrum and phenotype correlations of ABCA4-associated disease in patients of south Asian descent. Eur J Hum Genet, doi:https:\/\/doi.org\/10.1038\/ejhg.2017.13 (2017).","DOI":"10.1038\/ejhg.2017.13"},{"key":"11679_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10633-013-9420-z","volume":"128","author":"E Nong","year":"2014","unstructured":"Nong, E., Lee, W., Merriam, J. E., Allikmets, R. & Tsang, S. H. Disease progression in autosomal dominant cone-rod dystrophy caused by a novel mutation (D100G) in the GUCA1A gene. Doc Ophthalmol \n                           128, 59\u201367, doi:https:\/\/doi.org\/10.1007\/s10633-013-9420-z (2014).","journal-title":"Doc Ophthalmol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11679-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:44:32Z","timestamp":1671792272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11679-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11679"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11679-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]},"assertion":[{"value":"30 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11170"}}